Edison Investment Research - OTC Markets Group Cl A (OTCM) OTC Markets Group - Growing revenues and investing for the future

Report

Edison Investment Research

Andrew Mitchell

OTC Markets Group - Growing revenues and investing for the future

OTC Markets Group’s (OTCM) third quarter results showed further progress with pre-tax profits up by 4% versus Q316 despite a 10% increase in operating expenses to support IT systems and new services. OTCQX and OTCQB received Blue Sky recognition from a further two states taking the total to 27 for OTCQX. Strategic alliances have been established that should help extend OTCM’s geographical reach and broaden the services offered to corporate clients.

16/11/2017 9 EN

Underlying

OTC Markets Group Cl A

See profile

US67106F1084 Pink OTC Markets United States

Provider

Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

See profile

Analysts

Andrew Mitchell

Other Reports on these Companies

GlobeNewsWire

OTC Markets Group Welcomes Roth CH Acquisition Co. to OTCQX

OTC Markets Group Welcomes Roth CH Acquisition Co. to OTCQX NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced (OTCQX: USCTF), a special purpose acquisition company, has qualified to trade on the OTCQX® Best Market. Roth CH Acquisition Co. previously traded on NASDAQ. Roth CH Acquisition Co. begins trading today on OTCQX under the symbol “USCTF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on . Trading on the OTCQX Market of...

April 25, 2024 April 25, 2024 1 EN

GlobeNewsWire

OTC Markets Group Welcomes Exodus Movement, Inc. to OTCQX

OTC Markets Group Welcomes Exodus Movement, Inc. to OTCQX NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) -- (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced (OTCQX: EXOD), a non-custodial cryptocurrency software platform, has qualified to trade on the OTCQX® Best Market. Exodus Movement, Inc. upgraded to OTCQX from the OTCQB® Venture Market. Exodus Movement, Inc. begins trading today on OTCQX under the symbol “EXOD.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on . The OT...

April 12, 2024 April 12, 2024 1 EN

GlobeNewsWire

OTC Markets Group Welcomes Team Internet Group PLC to OTCQX

OTC Markets Group Welcomes Team Internet Group PLC to OTCQX NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) -- (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced (AIM: TIG; OTCQX: TIGXF), a leading global internet solutions company, has qualified to trade on the OTCQX® Best Market. Team Internet Group PLC upgraded to OTCQX from the Pink® market. Team Internet Group PLC begins trading today on OTCQX under the symbol “TIGXF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on . ...

April 9, 2024 April 9, 2024 1 EN

AGBA - A transformational deal

On 18 April, AGBA announced a surprise deal to acquire 100% of Triller Corp, a global AI-driven social video platform, in an all-stock transaction. Triller is privately-owned but has been independently valued at US$3.2bn. AGBA’s management is using a US$4bn valuation for the combined entity, in which AGBA shareholders will own 20% and Triller shareholders 80%. Triller recorded FY23 revenues of US$45m on 450m user accounts and 2.2m creators but is loss-making. In FY23, AGBA reported revenues of US$54m and 400,000+ clients. The combined group expects synergies from expanding and marketing to Tri...

10h / 46m 10h / 46m 1 EN

Sean Conroy

Sean Conroy

Biodexa Pharmaceuticals - In a period of transition

FY23 was a transitional year for Biodexa, following the restructuring announced in March 2023 into a therapeutic company from a drug delivery specialist, and the implementation of cost-saving initiatives in light of the macroeconomic environment. The pipeline expansion primarily de-risks the business, partially fulfilled with the acquisition of lyn kinase activator tolimidone, for type 1 diabetes (T1D), in late 2023. Management estimates gross cash of £5.97m at end-FY23 to provide a runway into Q424, past the planned Phase IIa trial initiation for tolimidone. The next catalyst will likely be t...

14h / 55m 14h / 55m 1 EN

Toby Thorrington

Toby Thorrington

Norcros - Sale of Johnson Tiles UK agreed

Norcros’s disposal of Johnson Tiles is the latest strategic activity taken by management to better allocate capital to fit with priorities. Last year it closed its UK adhesives operation. Norcros has a compelling investment case, where its new product development initiatives, market positioning and self-help initiatives allow it to take market share in both the UK and South Africa. Its rating is low at 6.0x FY24e P/E, which is attractive, especially when compared to its yield of 5.4% on its well-covered dividend. We retain our estimates and value the shares at 246p, implying c 30% upside.

April 25, 2024 April 25, 2024 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

OTC Markets Group - Growing revenues and investing for the future

OTC Markets Group Welcomes Roth CH Acquisition Co. to OTCQX

OTC Markets Group Welcomes Exodus Movement, Inc. to OTCQX

OTC Markets Group Welcomes Team Internet Group PLC to OTCQX

AGBA - A transformational deal

Biodexa Pharmaceuticals - In a period of transition

Norcros - Sale of Johnson Tiles UK agreed

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe